FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics and represents a medicinal agent applicable for treating a polycystic kidney disease and containing a compound presented by the following structural formula:
or a pharmaceutically acceptable salt thereof.
EFFECT: invention provides extending the range of agents applicable for treating the polycystic kidney disease.
13 cl, 4 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING POLYCYSTIC KIDNEY DISEASES BY CERAMIDE DERIVATIVES | 2008 |
|
RU2517345C9 |
| ARYL, HETEROARYL AND HETEROCYCLIC PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF MEDICAL DISORDERS | 2018 |
|
RU2801278C2 |
| COMPOUNDS, COMPOSITIONS AND METHODS FOR INCREASING CFTR ACTIVITY | 2015 |
|
RU2767460C2 |
| METHOD FOR PREPARING HERBICIDE DERIVATIVES AND INTERMEDIATE COMPOUND | 2000 |
|
RU2244715C2 |
| NMDA RECEPTOR MODULATORS AND THEIR APPLICATION | 2012 |
|
RU2621049C2 |
| PROTEOLYSIS MODULATORS AND RELATED USES | 2019 |
|
RU2805511C2 |
| IDO INHIBITORS | 2012 |
|
RU2613579C2 |
| BRIDGED N-CYCLYC SULPHONAMIDO-INHIBITORS OF GAMMA-SECRETASE | 2006 |
|
RU2422443C2 |
| CONDENSED DERIVATIVES OF IMIDAZOLE AND PYRAZOLE AS MODULATORS OF ACTIVITY TNF | 2014 |
|
RU2686117C1 |
| 5-(7H-PYRROLO[2,3-d]PYRIMIDINE-4-YL)-5-AZASPIRO[2.5]OCTANE-8-CARBOXYLIC ACID DERIVATIVES AS NEW JAK-KINASE INHIBITORS | 2018 |
|
RU2761626C2 |
